Patents Assigned to ADDIENE SRL
  • Anti-C5 Alpha Antibodies
    Publication number: 20120009184
    Abstract: The present invention refers to recombinant antibodies of human origin specific for the C5 component of the activated complement and characterised by the ability to inhibit the conversion of the C5 alpha chain to C5a and C5b. Moreover the present invention refers to the nucleotide sequences coding for such antibodies and to the therapeutic use of both polypeptide and nucleotide sequences, in particular for the therapy of diseases involving tissue damage deriving from uncontrolled activation of the complement system.
    Type: Application
    Filed: July 18, 2011
    Publication date: January 12, 2012
    Applicant: ADDIENE SRL
    Inventors: Francesco TEDESCO, Roberto Marzari